A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...
Newsflash: Great skin doesn’t happen overnight. As much as we want to believe that a singular anti-aging serum or under-eye ...
A new study co-written by a University of Illinois Urbana-Champaign expert in operations management finds that drugs approved ...
We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...
The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...
A clinical trial has shown that personalizing cancer treatments based on tumor DNA can improve treatment outcomes.
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today highlighted its strategic priorities and anticipated ...
Schrödinger, Inc. (Nasdaq: SDGR) provided an update on its progress across the business in 2025 and announced its strategic priorities for 2026. The company is continuing to focus on advancing its ...
MediWound Provides Corporate Update and Financial Outlook Ahead of the J.P. Morgan Healthcare ConferenceInterim assessment and enrollment ...
Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...
Antimicrobial resistance (AMR) threatens the effectiveness of standard anti-infective drugs and calls for therapeutic concepts that can bypass, disable, or ...
Sanofi (SAN:CA) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM ESTCompany ParticipantsPaul Hudson - CEO & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback